StonvexLoading…
StonvexStonvexStonvexCore line items from SLGN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-07-28 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $1.65B | $1.56B | $6.48B | $5.01B | $3.01B |
Operating Income | Not available | $84.15M | $408.50M | $355.12M | $206.45M |
Net Income | Not available | $63.04M | $288.40M | $270.20M | $156.91M |
EPS (Diluted) | $0.98 | $0.60 | $2.70 | $2.52 | $1.46 |
Total Assets | Not available | $9.32B | $9.40B | $9.50B | $9.41B |
Total Liabilities | Not available | Not available | Not available | Not available | Not available |
Cash & Equivalents | Not available | $435.43M | $1.08B | $389.17M | $317.46M |
Free Cash Flow OCF − CapEx | Not available | $-882.02M | $422.75M | $-799.76M | $-1.06B |
Shares Outstanding | Not available | 105.86M | 105.44M | 107.13M | 107.29M |